Title : Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.

Pub. Date : 2013 Aug 15

PMID : 23961322






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It is now evident that the vascular production of cGMP can be augmented by inhibitors of phosphodiesterase type 5 (PDE 5), the enzyme which breakdowns this cyclic nucleotide. Nucleotides, Cyclic phosphodiesterase 5A Homo sapiens
2 It is now evident that the vascular production of cGMP can be augmented by inhibitors of phosphodiesterase type 5 (PDE 5), the enzyme which breakdowns this cyclic nucleotide. Nucleotides, Cyclic phosphodiesterase 5A Homo sapiens